Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zuberitamab in Paediatric Steroid-sensitive Nephrotic Syndrome
NCT07765914Phase 3Not yet recruiting
- Sponsor
- Children's Hospital of Fudan University
- Start
- Aug 2026
- Primary completion
- Aug 2028
- Countries
- 1
01
Overview
A Phase 3 trial of hlx01 in nephrotic syndrome, sponsored by Children's Hospital of Fudan University. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
hlx01
03
Conditions
nephrotic syndrome
Beyond the preview
Go deeper on NCT07765914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07765914.